TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Arterial blood pressure (systolic and diastolic)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: lost days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PSQI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5‐HT content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Chance of treatment success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weeks before exercise can be completed free of pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Success in IOP control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in IOP fluctuation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean load to repair failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Mean load to ultimate failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: duration of breast feeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: women's experiences of breast feeding
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Morphine rescues required
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: increase of grey matter volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Antibody response to TIV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Severity of clinical symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Face Pain Score-Revised
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recognition of facial expressions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Memory intrusions for positive personality characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative subjective effects
Endpoint domain: Adverse events/effects
Primary endpoint: Total body clearance of mivacurium isomers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AAA growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distress levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean clinical activity index score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: local relapse rate
Endpoint domain: Mortality/survival
Primary endpoint: overall relapse rate
Endpoint domain: Mortality/survival
Primary endpoint: JT interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: T(peak)-T(end) interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Intraocular pressure (IOP) changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life - Kansas City Cardiomyopathy Questionnaire Clinical Summary Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Risk of HF hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: Pain intensity perception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Low back functional disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: grade ≥2 RISF
Endpoint domain: Adverse events/effects
Primary endpoint: RILA value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Worsening in any 2/6 CRV by >= 40%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fetal cardiac activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Ki-67 activity in fetal tissues
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: temporal pain summation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum adiponectin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delayed graft function (DGF)
Endpoint domain: Mortality/survival
Primary endpoint: Severe hypoglycemia (BG < 40 mg/dl)
Endpoint domain: Adverse events/effects
Primary endpoint: Severe hyperglycemia (BG > 350 mg/dl)
Endpoint domain: Adverse events/effects
Primary endpoint: Low-Density Lipoprotein (LDL) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: High-Density Lipoprotein (HDL) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: neurological deficit scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Physical complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cumulative risk of recurrent malaria within 84 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Tonsillar size after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Return to normal diet and activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HOMA insulin resistance index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area under the curve of glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Negative appendectomy rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: number of reinterventions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: risk of other cardiovascular events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Failure rate of inlays
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pulpal pain and persisting hypersensitivity
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of Respiratory Distress Syndrome (RDS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: SJFT performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: combat activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: narcotic consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Sequential Organ Failure Assessment score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nodal relapse-free survival (NRFS) rate
Endpoint domain: Mortality/survival
Primary endpoint: Local control rate
Endpoint domain: Mortality/survival
Primary endpoint: Response times to stepwise stimuli
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: frequency of adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: Cardiac sequelae (CS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: perceived low-back discomfort
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Right ventricle Tei index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Serum NT-proBNP level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pulmonary arterial systolic pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: HAMD score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TESS score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Root mean square of successive RR interval differences
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Baroreflex sensitivity (alpha-HF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Maturation index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: fireworks-related injuries
Endpoint domain: Adverse events/effects
Primary endpoint: sternal wound infections
Endpoint domain: Adverse events/effects
Primary endpoint: intragastric pH > 4 duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Lethargy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Combined QOL mean scores for parents
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Scores for sleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Scores for appetite
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: adjusted total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: responsive subsection scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of ventricular arrhythmia (VA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Preference for shared decision making (SDM)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Baseline oral temperature (Tor)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CVC in the NOS inhibited site
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Reduction in glycosylated hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cost-effectiveness of immunizations
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Lumbar flexion range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Angle of straight leg raising
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child mortality rate
Endpoint domain: Mortality/survival
Primary endpoint: Frequency of acute transports to hospitals
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Depression score (GDS-15)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Target vessel revascularization (TVR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Target lesion revascularization related major adverse cardiac events (TLR-MACE)
Endpoint domain: Adverse events/effects
Primary endpoint: Overall binary angiographic restenosis rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Major and minor bleeding events
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of death or myocardial infarction (MI)
Endpoint domain: Mortality/survival
Primary endpoint: Driving errors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall driving scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Termination of ODA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in correct INR ranges within ±0.5 units
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in correct INR ranges within ±0.75 units
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in bleeding events
Endpoint domain: Adverse events/effects
Primary endpoint: pain after surgery
Endpoint domain: Adverse events/effects
Primary endpoint: inflammation after surgery
Endpoint domain: Adverse events/effects
Primary endpoint: recurrence of pterygium
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative complications (SSI or pulmonary complications)
Endpoint domain: Adverse events/effects
Primary endpoint: T lymphocyte activation (CD69 expression)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of stools per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Regression of LV hypertrophy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in systolic/diastolic pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Health care utilization costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Frequency of allergic drug reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in GEA score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increases in eyelash length, thickness, and darkness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean reductions in intraocular pressure (IOP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Serum urea concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Clinical tolerance
Endpoint domain: Adverse events/effects
Primary endpoint: Acceptability of treatment options
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Preference for treatment options
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: sleep quality
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: number of arousals
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in treatment decisions based on EUS results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interobserver agreement (kappa values)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of EUS conclusions regarding stage or resectability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean pain scores during skin puncture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduced days of hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Increased quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: participant symptomatology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: parenting skills
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: children's abuse-related fear and general anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of Incomplete Stent Apposition (ISA) at follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Major adverse cardiac event free survival at 4 years
Endpoint domain: Mortality/survival
Primary endpoint: Area under the curve (AUC) of triazolam
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance in the DSST after triazolam dose
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Post-operative mean spherical equivalent
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HbA1c value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mortality hazards
Endpoint domain: Mortality/survival
Primary endpoint: Cases of suppuration
Endpoint domain: Adverse events/effects
Primary endpoint: Inflammatory reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Need for removal of sutures
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: improvements in physiological parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: nononcological liver morbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Sedentary activity levels
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Levels of EA derivatives and urolithins in colon tissues
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: occurrence of cardiovascular death, myocardial infarction, or repeated revascularization
Endpoint domain: Mortality/survival
Primary endpoint: Lymphocyte count increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Duration of manual ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Frequency of movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence proportion of any distressing event
Endpoint domain: Adverse events/effects
Primary endpoint: Intraoperative hemostasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Visualization of segmental bronchi
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: relative RMR (kJ.kg FFM-1.h-1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total WOMAC score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: WOMAC pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Anxiety reduction (DASS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Participation in childbirth preparation classes
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Natural delivery rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: longer hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: long treatment interruptions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: higher toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Accuracy in acoustic voice analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: preoperative haemoglobin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: likelihood of allogeneic blood transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incident diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Mean visual analog scale values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adjusted Odds Ratio (OR) for AISL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Curve (AUC) for distinguishing AISL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arousal score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of three-band RDT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of three-band RDT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive predictive value of three-band RDT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Root Coverage (REC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Keratinized Gingival (KG) gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maternal viral load as a predictor of MTCT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Correct utilization of personal protective equipment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: number of glucocorticosteroid side effects
Endpoint domain: Adverse events/effects
Primary endpoint: basal plasma cortisol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Average VO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Peripheral Resistance (TPR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percent reduction in parathyroid hormone from baseline to 20 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: risk of clinical fracture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: baseline serum calcium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: potential delirium onset
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: overall hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Oral hygiene index-simplified (OHI-S)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aortic crossclamp time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraoperative inotropic support
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: itch intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: impact scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Overall sleep disturbance (CSDI)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: FEV1 (forced expiratory volume in 1 second)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Upper abdominal pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Acid regurgitation score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes